Fig. 6.
Overall survival (OS) based on tumor MGMT promoter methylation status. Median OS for methylated MGMT was 65.3 weeks (95% CI, 40.4 weeks to not reached); median OS for unmethylated MGMT was 19.4 weeks (95% CI, 16.1–55.3 weeks). P = .07.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.